Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.
Journal
The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
20
12
2022
revised:
07
02
2023
accepted:
08
02
2023
medline:
28
3
2023
entrez:
25
3
2023
pubmed:
26
3
2023
Statut:
ppublish
Résumé
Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies. Such assessments can inform public health policies and contribute to evidence-based choices of NPIs during subsequent waves or future epidemics. However, methodological issues and no standardised assessment practices have restricted the practical value of the existing evidence. Here, we present and discuss lessons learned from the COVID-19 pandemic and make recommendations for standardising and improving assessment, data collection, and modelling. These recommendations could contribute to reliable and policy-relevant assessments of the effectiveness of NPIs during future epidemics.
Identifiants
pubmed: 36965985
pii: S2468-2667(23)00046-4
doi: 10.1016/S2468-2667(23)00046-4
pmc: PMC10036127
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e311-e317Subventions
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR200908
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests TS was a member of the Swiss National COVID-19 Science Task Force from March, 2020, to March, 2022, and its President from August, 2021, to March, 2022. TS has been President of the Swiss COVID-19 Scientific Advisory Panel since November, 2022. TS acknowledges service contracts with the Swiss Federal Office of Public Health on sequencing of Swiss SARS-CoV-2 samples, computation of effective reproduction numbers from wastewater data, and SARS-CoV-2 variant tracking and nowcasting. NMF undertook consultancy work for the World Bank Group on infectious disease threats until 2019, and was supported with travel expenses by WHO for WHO meetings. All other authors declare no competing interests.
Références
PLoS One. 2021 Jun 2;16(6):e0252827
pubmed: 34077448
J Prev Med Public Health. 2020 Sep;53(5):293-301
pubmed: 33070499
Nature. 2020 Dec;588(7839):E26-E28
pubmed: 33361787
Interface Focus. 2021 Oct 12;11(6):20210041
pubmed: 34956599
Patterns (N Y). 2021 Aug 13;2(8):100310
pubmed: 34405155
Nat Commun. 2020 Dec 3;11(1):6189
pubmed: 33273462
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
PLoS One. 2023 Feb 15;18(2):e0276906
pubmed: 36791127
Lancet Reg Health Eur. 2021 Aug;7:100148
pubmed: 34124709
Sci Rep. 2022 May 9;12(1):7526
pubmed: 35534516
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):
pubmed: 33820846
Sci Data. 2020 Aug 27;7(1):285
pubmed: 32855430
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33766888
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34162708
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
Epidemics. 2022 Jun;39:100585
pubmed: 35636312
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20210001
pubmed: 34053252
Science. 2021 Mar 26;371(6536):
pubmed: 33531384
Stat Med. 2021 Nov 30;40(27):6209-6234
pubmed: 34494686
J R Stat Soc Ser A Stat Soc. 2022 May 26;:
pubmed: 35942192
Nature. 2020 Dec;588(7839):E29-E32
pubmed: 33361788
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Nat Commun. 2021 Oct 5;12(1):5820
pubmed: 34611158
J Regul Econ. 2022;62(1-3):1-23
pubmed: 36035787
Euro Surveill. 2022 Mar;27(10):
pubmed: 35272745
PLoS Comput Biol. 2020 Dec 10;16(12):e1008409
pubmed: 33301457
Science. 2020 Jul 10;369(6500):
pubmed: 32414780
Nature. 2020 Sep;585(7825):410-413
pubmed: 32365354
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24144-24153
pubmed: 32934147
Environ Health Perspect. 2022 May;130(5):57011
pubmed: 35617001
Eur J Epidemiol. 2022 Oct;37(10):1003-1024
pubmed: 36152133
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):19837-19843
pubmed: 32732433
Lancet Digit Health. 2020 Dec;2(12):e658-e666
pubmed: 33078140
Sci Data. 2021 Aug 24;8(1):225
pubmed: 34429423
PLoS Med. 2022 Mar 1;19(3):e1003907
pubmed: 35231023
Epidemics. 2022 Sep;40:100612
pubmed: 35930904
Epidemics. 2022 Mar;38:100546
pubmed: 35183834
Euro Surveill. 2022 Oct;27(41):
pubmed: 36239171
Lancet. 2022 Apr 16;399(10334):1469-1488
pubmed: 35219376
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
J Econom. 2021 Jan;220(1):23-62
pubmed: 33100476